IMO, a great interview and eye opener for sure.
grandroundsinurology.com/in...
p.s. -- following next PSA I likely will begin my *T* injections again and get back to 1,600ng/dL
p.p.s. - apology if previously posted
IMO, a great interview and eye opener for sure.
grandroundsinurology.com/in...
p.s. -- following next PSA I likely will begin my *T* injections again and get back to 1,600ng/dL
p.p.s. - apology if previously posted
Can't find his new book
Maybe this one?
amazon.com/Truth-About-Men-...
I've seen an earlier case study he published with a good results for a handful of PCa patients but can't find it now.
Just my opinion: His points are well-reasoned and should be considered. He comes off as a bit of a testosterone evangelist. Not necessarily a bad thing, but as with any evangelist, take it with the number of grains of salt that make you comfortable.
How many mg/week is that dosage?
bilateral Orchiectomy in April 2015 and began Cypionate Jan 2016
1ml every 2 weeks of Cypionate 200MG/ML
Once on schedule then following the injection *T* tests at 1,600ng/dL then down to 450ng/dL to 600ng/dL before next injection
You should try .3ml every second day - that way the troughs even out and the serum levels are more even and fewer side effects too. Use an insulin needle - 29 gauge and 1/2 inch long - and inject into your delta or ventro-glutes.
Is Abe Mergenthaler still seeing patients?
I have to admit Iβm struggling to understand what's new here. I wasnβt aware that anyone believed that testosterone actually caused PCa otherwise every man would surely get the disease, wouldnβt they? However, even he concedes that once you have got the disease, lowering T (via ADT) shrinks the tumours.
He then says that raising T above 250 ng/dL doesnβt cause any further tumour growth. This may be true. Before I started ADT a year ago, my tumours were clearly growing and if I hadnβt gone onto ADT they would have continued growing. At that time my T was obviously somewhat higher than 250, so by his argument, lowering T just to 250 would do nothing and it had to be reduced to well below 250 (in fact, below 50) in order for the tumours to stop growing and start shrinking.
So surely all he is doing is confirming that if you want to shrink the tumours, you must make sure you reduce T to much lower than 250 β which we already knew is true.
What am I missing?
Benkaymel wrote -- " ... What am I missing? "
His opinion is DECADES OLD and remains contrary to much current day thinking by many. Thought (?) he was mentioning a T<20ng/dL for short time frame along with treatment and then no ADT allowing return to 250ng/dL (even higher) does not grow the PCa and allows the man a better QoL.
I didn't hear that and if you look at the graph in the referenced article it shows the rate of tumour growth increasing as T goes from zero to 250 where it then plateaus.
unfortunately nothing. Just means the drs have no idea what really causes the crap and treating it with drugs that makes us exhausted is all they have. Has to be hell being a transgender. Can you imagine doing that intentionally?
Not sure, but I think what he's saying that high-T for men with PCa is not as dangerous as once thought and does have QoL benefits. Sounds like it's related to Bipolar Androgen Therapy.
That may be true for men who are not metastatic but if you have mets, high T will let them grow faster.
Confused. BAT alternates supraphysiological levels of T with castrate levels. It is only recommended for mCRPC patients. For those who respond to this treatment, there are extended periods with no sign of disease progression. This is documented in Phase 2 trials. Since all patients in these trials are metastatic, the results seem to be at odds with your assertion.
ncbi.nlm.nih.gov/pmc/articl....
below quoted from ^^^
" ... Bipolar androgen therapy (BAT) is an emerging treatment strategy for patients with metastatic castration-resistant prostate cancer (mCRPC). During BAT, serum testosterone is cycled from supraphysiologic down to near-castrate levels every month [1]... "
I don't think it's recommended for symptomatic metastatic cases like me.
The problem with Morgentaler's model is that he totally ignores the effect of membrane androgen receptors. There is evidence to suggest that barring unusual mutations, in order for PCa to thrive it needs to have a relative balance between the agonism to intracellular androgen receptor and the agonism to membrane androgen receptor. For a detailed description of why this is so, see: tbiomed.biomedcentral.com/a...
^^^ article was Published 01 August 2007. His interview was *Posted by Neil H. Baum, MD | Feb 2023*
The date that an article has been published is irrelevant. The question is whether the article is factual or not. It is wrong to assume that all researchers are aware of all pertinent articles in their field. E.g., in 2008 it was shown that, without a doubt, the cause of prostate cancer is high local levels of estradiol acting on estrogen receptor-alpha. However, to this day it is hard to find any doctor or researcher who is aware of this fact. See: pubmed.ncbi.nlm.nih.gov/180...
More of the same.
I wonder why Morgentaler focuses on Total Testosterone and not Free T or Bioavailable T, which would seem to be much more relevant.
Thanks for posting this information, very interesting, cheers DD π.
Dr. Abraham Morgentaler is all over the internet....
Good Luck, Good Health and Good Humor.
j-o-h-n Tuesday 03/07/2023 11:02 PM EST
You are the βTβ master ! Go t! ππππ
Only a T man could split a boar in half with his bike lol.